These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of autoinflammatory syndromes. Gattorno M; Martini A Curr Opin Pediatr; 2010 Dec; 22(6):771-8. PubMed ID: 20966753 [TBL] [Abstract][Full Text] [Related]
3. Treatment of hereditary autoinflammatory diseases. Ter Haar NM; Frenkel J Curr Opin Rheumatol; 2014 May; 26(3):252-8. PubMed ID: 24667287 [TBL] [Abstract][Full Text] [Related]
4. The challenge of autoinflammatory syndromes: with an emphasis on hyper-IgD syndrome. van der Meer JW; Simon A Rheumatology (Oxford); 2016 Dec; 55(suppl 2):ii23-ii29. PubMed ID: 27856657 [TBL] [Abstract][Full Text] [Related]
5. Monogenic Periodic Fever Syndromes: Treatment Options for the Pediatric Patient. Ozen S; Demir S Paediatr Drugs; 2017 Aug; 19(4):303-311. PubMed ID: 28497352 [TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and Clinical Examination of Autoinflammatory Syndrome]. Ida H Rinsho Byori; 2015 May; 63(5):598-604. PubMed ID: 26524899 [TBL] [Abstract][Full Text] [Related]
8. IL-1 blockade in autoinflammatory syndromes. Jesus AA; Goldbach-Mansky R Annu Rev Med; 2014; 65():223-44. PubMed ID: 24422572 [TBL] [Abstract][Full Text] [Related]
9. [Pathogenesis and Clinical Examination of Autoinflammatory Syndrome]. Ida H Rinsho Byori; 2015 Oct; 63(10):1207-12. PubMed ID: 26897858 [TBL] [Abstract][Full Text] [Related]
10. The Central Role of Anti-IL-1 Blockade in the Treatment of Monogenic and Multi-Factorial Autoinflammatory Diseases. Federici S; Martini A; Gattorno M Front Immunol; 2013 Oct; 4():351. PubMed ID: 24198817 [TBL] [Abstract][Full Text] [Related]
13. The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist. Romano M; Arici ZS; Piskin D; Alehashemi S; Aletaha D; Barron KS; Benseler S; Berard R; Broderick L; Dedeoglu F; Diebold M; Durrant KL; Ferguson P; Foell D; Hausmann J; Jones OY; Kastner DL; Lachmann HJ; Laxer RM; Rivera D; Ruperto N; Simon A; Twilt M; Frenkel J; Hoffman H; de Jesus AA; Kuemmerle-Deschner JB; Ozen S; Gattorno M; Goldbach-Mansky R; Demirkaya E Ann Rheum Dis; 2022 Jul; 81(7):907-921. PubMed ID: 35623638 [TBL] [Abstract][Full Text] [Related]
14. Rare hereditary autoinflammatory disorders: towards an understanding of critical in vivo inflammatory pathways. Kanazawa N J Dermatol Sci; 2012 Jun; 66(3):183-9. PubMed ID: 22336993 [TBL] [Abstract][Full Text] [Related]
15. Autoinflammatory Diseases with Periodic Fevers. Sag E; Bilginer Y; Ozen S Curr Rheumatol Rep; 2017 Jul; 19(7):41. PubMed ID: 28631068 [TBL] [Abstract][Full Text] [Related]
16. IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives. Malcova H; Strizova Z; Milota T; Striz I; Sediva A; Cebecauerova D; Horvath R Front Immunol; 2020; 11():619257. PubMed ID: 33603750 [TBL] [Abstract][Full Text] [Related]
17. The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist. Romano M; Arici ZS; Piskin D; Alehashemi S; Aletaha D; Barron K; Benseler S; Berard RA; Broderick L; Dedeoglu F; Diebold M; Durrant K; Ferguson P; Foell D; Hausmann JS; Jones OY; Kastner D; Lachmann HJ; Laxer RM; Rivera D; Ruperto N; Simon A; Twilt M; Frenkel J; Hoffman HM; de Jesus AA; Kuemmerle-Deschner JB; Ozen S; Gattorno M; Goldbach-Mansky R; Demirkaya E Arthritis Rheumatol; 2022 Jul; 74(7):1102-1121. PubMed ID: 35621220 [TBL] [Abstract][Full Text] [Related]
18. Periodic fevers and other autoinflammatory diseases. Fingerhutová Š; Jančová E; Tesařová M; Dvořáková L; Doležalová P Cas Lek Cesk; 2018; 157(3):122-129. PubMed ID: 30441946 [TBL] [Abstract][Full Text] [Related]